share_log

Olema Pharmaceuticals | 8-K: Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update

SEC announcement ·  Mar 11 16:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more